跳至主要内容
临床试验/DRKS00009318
DRKS00009318已完成未知

Randomised controlled trial testing the effectiveness of a new multi-professional Breathlessness sErvice for patients with any Advanced diSease against usual care (BreathEase) - BreathEase

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 183 人开始时间: 2015年11月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
183

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • i) Patients affected by breathlessness due to any advanced life-limiting and progressive disease, despite treatment of the underlying condition
  • ii) Patients capable (in a cognitive and functional manner) to participate in the intervention including outpatient clinic and physiotherapist visits as well as self- management iii) If patients are suffering from acute exacerbations of the underlying conditions, they are put on a waiting list for two to four weeks and are then entered into the trial.

排除标准

  • i) Patients suffering from breathlessness due to chronic hyperventilation syndrome, asthma or any other unknown cause
  • ii) Cancer patients under concurrent initial or full dose systemic treatment or radiotherapy (except on
  • maintenance therapy)
  • iii) Patients participating in any drug trial targeting the treatment of the underlying condition/ illness

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验